Effect of SAR445611 on inflammatory responses following LPS challenge study in healthy participants
Phase 1
Recruiting
- Conditions
- Immune system diseasesTherapeutic area: Diseases [C] - Immune System Diseases [C20]
- Registration Number
- CTIS2024-511618-19-00
- Lead Sponsor
- Sanofi-Aventis Recherche & Developpement
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Male
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method